Literature DB >> 16544935

Alymphoplasia mice are resistant to prion infection via oral route.

Motohiro Horiuchi1, Hidefumi Furuoka, Nobuo Kitamura, Morikazu Shinagaw.   

Abstract

The major cause of infection in animal prion diseases is thought to be consumption of prion-contaminated stuff. There is evidence that the enteric nerve system (ENS) and gut-associated lymphoid tissues (GATL) are involved in the establishment of prion infection through alimentary tract. To elucidate the initial entry port for prion, we inoculated prion to alymphoplasia (aly) mice showing a deficiency in systemic lymph nodes and Peyer's patches. The aly/aly mice were susceptible to prion infection by intra-cranial inoculation and there were no differences in incubation periods between aly/aly mice and wild-type C57BL/6J mice. Incubation periods in aly/aly mice were about 20 days longer than those in C57BL/6J mice with the intra-peritoneal inoculation. The aly/aly mice were completely resistant to prion infection by per os administration, while C57BL/6J mice were sensitive as they entered the terminal stage of disease around 300 days post inoculation. PrP(Sc) were detected in the intestine and spleen of C57BL/6J mice inoculated with prion intraperitoneally or orally; however PrP(Sc) was not detected in the spleen and intestine of aly/aly mice. Prion infectivity was detected in the intestines and spleens of prion-inoculated C57BL/6J mice, even after the early stages of exposure, while no infectivity was detected in these tissues of prion-inoculated aly/aly mice. No apparent differences were observed in the organization of the enteric nerve system between wild-type and aly/aly mice. These results indicate that GALT rather than ENS acts as the primary entry port for prion after oral exposure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16544935

Source DB:  PubMed          Journal:  Jpn J Vet Res        ISSN: 0047-1917            Impact factor:   0.649


  9 in total

1.  Follicular dendritic cell-specific prion protein (PrP) expression alone is sufficient to sustain prion infection in the spleen.

Authors:  Laura McCulloch; Karen L Brown; Barry M Bradford; John Hopkins; Mick Bailey; Klaus Rajewsky; Jean C Manson; Neil A Mabbott
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

2.  Increased Abundance of M Cells in the Gut Epithelium Dramatically Enhances Oral Prion Disease Susceptibility.

Authors:  David S Donaldson; Anuj Sehgal; Daniel Rios; Ifor R Williams; Neil A Mabbott
Journal:  PLoS Pathog       Date:  2016-12-14       Impact factor: 6.823

Review 3.  How do PrPSc Prions Spread between Host Species, and within Hosts?

Authors:  Neil A Mabbott
Journal:  Pathogens       Date:  2017-11-24

4.  Prion disease pathogenesis in the absence of the commensal microbiota.

Authors:  Barry M Bradford; Laura Tetlow; Neil A Mabbott
Journal:  J Gen Virol       Date:  2017-07-15       Impact factor: 3.891

5.  Oral Prion Disease Pathogenesis Is Impeded in the Specific Absence of CXCR5-Expressing Dendritic Cells.

Authors:  Barry M Bradford; Boris Reizis; Neil A Mabbott
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

6.  Oral Prion Neuroinvasion Occurs Independently of PrPC Expression in the Gut Epithelium.

Authors:  Alison Marshall; Barry M Bradford; Alan R Clarke; Jean C Manson; Neil A Mabbott
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

7.  Effect of co-infection with a small intestine-restricted helminth pathogen on oral prion disease pathogenesis in mice.

Authors:  Alejandra Sánchez-Quintero; Barry M Bradford; Rick Maizels; David S Donaldson; Neil A Mabbott
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

8.  The Gut-Associated Lymphoid Tissues in the Small Intestine, Not the Large Intestine, Play a Major Role in Oral Prion Disease Pathogenesis.

Authors:  David S Donaldson; Kathryn J Else; Neil A Mabbott
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

Review 9.  The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis.

Authors:  Neil A Mabbott; Barry M Bradford; Reiss Pal; Rachel Young; David S Donaldson
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.